What is Upheal?
Based in Prague, Upheal is at the forefront of digital transformation in mental healthcare. The company offers an advanced AI-powered platform designed to assist therapists and clinicians by streamlining their administrative burdens. Key features include automated progress note generation and efficient treatment plan creation, allowing practitioners to dedicate more time to patient care. This focus on operational efficiency positions Upheal as a critical tool for mental health professionals navigating an increasingly complex healthcare landscape.
How much funding has Upheal raised?
Upheal has raised a total of $14.3M across 3 funding rounds:
Other Financing Round
$1M
Angel/Seed
$3.3M
Series A
$10M
Other Financing Round (2022): $1M with participation from Calm/Storm Ventures, Juraj Masar, Kaya Vc, and Credoventures
Angel/Seed (2024): $3.3M led by Inovia, Credoventures, and Kaya Vc
Series A (2024): $10M supported by Kaya Ventures, Headline, and Credoventures
Key Investors in Upheal
Kaya Ventures
Kaya Ventures is a thesis-driven investment firm focused on advancing healthcare innovation, particularly in women's health, caregiving, and digital health. They identify and support early-stage companies that address significant gaps in the healthcare market, providing guidance and tools for growth.
Headline
Headline is a venture capital firm that partners with fast-growing technology teams in key geographies to make their success global. Their Global Growth Fund invests globally from Series B and beyond, allowing them to identify local trends and lead rounds at every stage.
Credoventures
Credo Ventures is a venture capital fund that supports ambitious founders from Central and Eastern Europe, focusing on pre-seed investments. They work closely with technical founders to build generational companies and have backed over 100 companies.
What's next for Upheal?
With the recent major strategic investment, Upheal is poised for significant expansion and further development of its AI capabilities. The substantial enterprise-level funding suggests a focus on scaling operations, enhancing its technological infrastructure, and potentially broadening its market reach. This capital infusion will likely enable Upheal to solidify its position as a leader in the HealthTech space, driving innovation in how mental health services are delivered and managed. Future growth may involve deeper integration with existing healthcare systems and the development of new AI-driven features to support a wider range of clinical needs.
See full Upheal company page
